Interferon regulatory factor-1 immunoreactivity in neurons and inflammatory cells following ischemic stroke in rodents and humans

[1]  Jun Chen,et al.  Programmed Cell Death in Cerebral Ischemia , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  C. Iadecola,et al.  Cerebral ischemia and inflammation , 2001, Current opinion in neurology.

[3]  J. Melki,et al.  Interferons and IRF-1 Induce Expression of the Survival Motor Neuron (SMN) Genes , 2000, Molecular medicine.

[4]  H. Jockusch,et al.  Tumor Necrosis Factor α Induces a Metalloprotease-Disintegrin, ADAM8 (CD 156): Implications for Neuron–Glia Interactions during Neurodegeneration , 2000, The Journal of Neuroscience.

[5]  K. Ozato,et al.  Interferon Regulatory Factor (Irf)-1 and Irf-2 Regulate Interferon γ–Dependent Cyclooxygenase 2 Expression , 2000, The Journal of experimental medicine.

[6]  G. Feuerstein,et al.  Inflammation and Stroke: Putative Role for Cytokines, Adhesion Molecules and iNOS in Brain Response to Ischemia , 2000, Brain pathology.

[7]  F. Barone,et al.  Inflammatory Mediators and Stroke: New Opportunities for Novel Therapeutics , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[8]  Yuan Zhang,et al.  Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein. , 1999, Science.

[9]  M. Ross,et al.  Cyclooxygenase-2 immunoreactivity in the human brain following cerebral ischemia , 1999, Acta Neuropathologica.

[10]  J B Schulz,et al.  Caspases as treatment targets in stroke and neurodegenerative diseases , 1999, Annals of neurology.

[11]  M. Ross,et al.  Inducible nitric oxide synthase expression in human cerebral infarcts , 1999, Acta Neuropathologica.

[12]  C. Iadecola,et al.  The Transcription Factor Interferon Regulatory Factor 1 Is Expressed after Cerebral Ischemia and Contributes to Ischemic Brain Injury , 1999, The Journal of experimental medicine.

[13]  W. Paschen,et al.  Changes in interferon‐regulatory factor‐1 mRNA levels after transient ischemia in rat brain , 1998, Neuroreport.

[14]  V. Lakics,et al.  Lipopolysaccharide and ceramide use divergent signaling pathways to induce cell death in murine macrophages. , 1998, Journal of immunology.

[15]  J. Hallenbeck.  Cytokines, macrophages, and leukocytes in brain ischemia , 1997, Neurology.

[16]  M. Ross,et al.  Cyclo-Oxygenase-2 Gene Expression in Neurons Contributes to Ischemic Brain Damage , 1997, The Journal of Neuroscience.

[17]  N. Rothwell,et al.  Cytokines and acute neurodegeneration , 1997, Molecular Psychiatry.

[18]  A. Sica,et al.  A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter , 1995, The Journal of experimental medicine.

[19]  T. Taniguchi,et al.  An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes , 1995, Nature.

[20]  T. Taniguchi,et al.  Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. , 1994, Science.

[21]  C. Nathan,et al.  Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. , 1994, The Journal of biological chemistry.

[22]  T. Taniguchi,et al.  Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-β gene regulatory elements , 1988, Cell.

[23]  T. Taniguchi,et al.  IRF family of transcription factors as regulators of host defense. , 2001, Annual review of immunology.